Institutional investors love Big Pharma stocks, and there’s a strong reason why. The sector is an important linchpin of the healthcare system, providing life-saving treatments to millions of people. Our latest addition to the Best Healthcare Dividend Stocks List is a familiar name that continues to provide value thanks to its vast treatment catalog, dependable dividend payments and consistent earnings growth.
Losing out on a patent usually spells bad news for pharmaceutical companies, but for our pick, a vast product catalog of essential treatments helps to mitigate the losses. Our pick invests extensively in research and development, putting it among the leaders for healthcare innovation. Don’t expect to earn a massive dividend with our pick – but expect a sustainable income stream every quarter as its underlying business continues to thrive.
To make room for our biotech pick, we’ve booked profits and removed a pharmaceutical research and development company whose recent growth has fizzled out.
You can check out the Best Healthcare Dividend Stocks List to explore all the stocks.
